TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/28/24 18:01 | 3/27/24 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hasnain Faheem | CA | DO | P,CEO | S | -27 | 1.16 | 0 | -23 | 0 | 5,156 | D | ||||||||||||||
8/14/23 16:41 | 8/11/23 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hasnain Faheem | CA | D | P | 300 | 27.80 | 0 | 11 | 72 | 26 | I | |||||||||||||||
3/22/23 17:14 | 3/20/23 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hasnain Faheem | CA | DO | P,CEO | P.dm | 1,000 | 1.14 | 0 | 879 | 23 | 4,639 | I | ||||||||||||||
7/15/22 16:21 | 7/15/22 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hasnain Faheem | CA | DO | P,CEO | P | 1,000 | 7.21 | 0 | 139 | 4 | 3,761 | I | ||||||||||||||
3/24/22 16:55 | 3/23/22 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hasnain Faheem | CA | DO | P,CEO | S | -170 | 8.92 | 0 | -19 | -1 | 3,622 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |